Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Clinical trial NCT02882282 · COMPLETED

Trial details

NCT number: NCT02882282
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Oral Cavity Carcinoma Oral Intraepithelial Neoplasia

Start date: 2017-06-14
Primary completion: 2025-07-14
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.